Generic Industry Sues To Halt Maryland's 'Price Gouging' Law
Executive Summary
Association for Accessible Medicines says sweeping price restraints on off-patent and generic drugs are vague and will 'unleash a potentially unlimited number of enforcement actions.'
You may also be interested in...
Maryland 'Price Gouging' Law's Loss In Court Could Derail Similar Legislation
States will likely need to craft different legislation on Rx prices after Fourth Circuit rules Maryland's statute violates Commerce Clause because it regulates transactions outside state.
Generics Firms Can't Halt Maryland's 'Price Gouging' Law
Judge rejects Association for Accessible Medicines' bid for preliminary injunction, but industry can still pursue claims the statute's language is unconstitutionally vague; law goes into effect Oct. 1.
Generics Firms Can't Halt Maryland's 'Price Gouging' Law
Judge rejects Association for Accessible Medicines' bid for preliminary injunction, but industry can still pursue claims the statute's language is unconstitutionally vague; law goes into effect Oct. 1.